(Q39547921)

13 September 2017

Plasma Leptin in Patients at Intermediate to High Cardiovascular Risk With and Without Type 2 Diabetes Mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

1 reference

11

Giuseppe Lippi

2 references

13 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

4

Massimo Franchini

1 reference

13 September 2017

1

Martina Montagnana

2 references

13 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

10

Gian Cesare Guidi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

3

Giovanni Targher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

8

Gian Luca Salvagno

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

4

Massimo Franchini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

5

Elisa Danese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

author name string

Cristiano Fava

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

Sara Bonafini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

Angela De Cata

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

Orazio Ruzzenente

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

language of work or name

1 reference

29 July 2016

1 reference

Journal of Clinical Laboratory Analysis

13 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

Positional cloning of the mouse obese gene and its human homologue

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Threading analysis suggests that the obese gene product may be a helical cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin resistance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Narrative review: the role of leptin in human physiology: emerging clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Molecular and anatomical determinants of central leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Adiposity signaling and biological defense against weight gain: absence of protection or central hormone resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Elevated leptin: consequence or cause of obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

High plasma immunoreactive leptin level in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin is associated with increased risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Sympathetic and cardiorenal actions of leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin and hyperleptinemia - from friend to foe for cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin and lipid metabolism in chronic kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Visceral obesity and metabolic syndrome: two faces of the same medal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Association of serum leptin levels with homeostasis model assessment-estimated insulin resistance and metabolic syndrome: the key role of central obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Relationship between leptin and C-reactive protein in young Finnish adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin mediates the increase in blood pressure associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Serum leptin levels in type 1 diabetic and obese children: relation to insulin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Plasma leptin and insulin relationships in obese and nonobese humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin and ghrelin expression in adipose tissues and serum levels in gastric banding patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Adipokines as novel modulators of lipid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Direct and indirect effects of leptin on adipocyte metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Leptin, adiponectin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blacks with and without coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg Study 1984-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22031

Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients

21 January 2018

1 reference

12 December 2020

Clinical endocrinology of human leptin

1 reference

12 December 2020

2. Classification and Diagnosis of Diabetes

1 reference

12 December 2020

Low plasma leptin levels in well controlled type 2 diabetes are not related to body fat mass and whole-body insulin resistance

1 reference

12 December 2020

The lost correlation between leptin and CRP in type 2 diabetes.

1 reference

12 December 2020

Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/insulin ratio in non-diabetic subjects

1 reference

12 December 2020

Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity

1 reference

12 December 2020

Hormones, metabolism and body composition as major determinants of blood rheology: potential pathophysiological meaning.

1 reference

12 December 2020

Depot-specific differences in adipose tissue gene expression in lean and obese subjects

1 reference

12 December 2020

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

1 reference

12 December 2020

Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men

1 reference

12 December 2020

Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects

1 reference

12 December 2020

Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates.

1 reference

12 December 2020

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

12 December 2020

Leptin induces oxidative stress in human endothelial cells.

1 reference

12 December 2020

Serum leptin levels in obese Indian children relation to clinical and biochemical parameters.

1 reference

12 December 2020

The "metabolically-obese," normal-weight individual.

1 reference

12 December 2020

Identifiers

DOI

10.1002/JCLA.22031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6817253&resulttype=core&format=json

12 May 2020

1 reference